Anti-reflux mucosectomy (ARMS) may be a new therapy for refractory gastroesophageal reflux disease (RGERD). The aim of the present study is to explore the safety and efficacy of ARMS.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
20
Anti-reflux mucosectomy (ARMS) may be a new therapy for refractory gastroesophageal reflux disease (RGERD). The aim of the present study is to explore the safety and efficacy of ARMS.
Zhongda Hospital Southeast University
Nanjing, Jiangsu, China
RECRUITINGImprovement of symptoms
Improvement of all the symptoms related with RGERD.
Time frame: 1 month, 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months
Complications of ARMS
Complications of ARMS,such as esophageal stenosis and dysphagia.
Time frame: 1 month, 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.